ImmunoSphere

ImmunoSphere is a biotechnology company specializing in the development of personalized cancer immunotherapies, specifically neoantigen-based vaccines. As a spin-off from Chulalongkorn University in Thailand, the company leverages a proprietary computational platform to identify patient-specific tumor mutations and design tailored vaccines. Their approach aims to stimulate a robust T-cell response against cancer cells while minimizing off-target toxicity. ImmunoSphere's lead programs are currently in the pre-clinical stage, with a focus on treating various solid tumors including melanoma and lung cancer. The company represents a significant advancement in the regional deep-tech ecosystem, aiming to provide accessible precision medicine solutions.